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Ionizing radiation activates immediately early genes, such as
c-jun, c-fos and nuclear factor kB (NF-kB) (Hallahan et al, 1991;
Wilson et al, 1993; Mohan and Meltz, 1994). The products of these
genes are transcription factors involved in regulation of the gene
expression associated with cell growth, healing of tissue injury and
inflammation. Transfection with certain oncogenes has been found
to cause cellular radiation resistance (Sklar, 1988; Kasid et al,
1989; Pirollo et al, 1993). These results suggest that related
signalling pathways may be involved in acquisition of radiation
resistance. It has been demonstrated that introduction of a trun-
cated IkB-a corrected both hypersensitivity to ionizing radiation
and the aberrant activation of NF-kB in ataxia telangectasia (AT)
cells (Jung et al, 1995). Therefore, activation of transcription
factor(s) may be involved in cellular radiosensitivity.
One of the proteins of the Rel/NF-kB family, NF-kB, is a tran-
scription factor which binds specifically to kB motifs as homo-
or heterodimers and regulates the expression of many genes
(reviewed in Baeuerle, 1991; Verma et al, 1995). The activation
and regulation of NF-kB are tightly controlled by IkB-a, a cellular
inhibitory protein of NF-kB. Normally, IkB-a binds to NF-kB,
thereby preventing the translocation of NF-kB into nucleus
(Baeuerle and Baltimore, 1988; Beg et al, 1992). Some of the
stimuli including tumour necrosis factor-a (TNF-a), ultra-violet
(UV) and ionizing radiation cause the degradation and disappear-
ance of IkB-a (Alkalay et al, 1995; Scherer et al, 1995), and then
the NF-kB translocates to the nucleus.
Phosphorylation is involved in the regulation of the activity of
many transcription factors. The NF-kB is a critical regulator of
cytokine-inducible gene expression (Baeuerle and Henkel, 1994).
Most importantly, phosphorylation regulates activity of the
inhibitor IkB-a, which sequesters NF-kB in the cytosol. For the
activation of NF-kB, two different pathways for the phosphoryla-
tion of IkB-a are demonstrated. One is serine (at residues 32 and
36) phosphorylation, which induces subsequent ubiquitin-depen-
dent degradation of IkB-a (Brockman et al, 1995; Brown et al,
1995; Traenckner et al, 1995). The other is tyrosine (at residue 42)
phosphorylation, which has the potential to directly couple NF-kB
to surface receptor associated tyrosine kinases, but not induce the
degradation of IkB-a (Imbert et al, 1996).
We constructed three different types of expression plasmids,
such as S-IkB containing Ser-to-Arg (AGC-CGC) mutations at
residues 32 and 36, Y-IkB containing Tyr-to-Phe (TAC-TTC)
mutation at residue 42, and SY-IkB containing all these mutations.
To assess the role of NF-kB activation on cellular sensitivity to
X-rays, adriamycin and UV, we examined the sensitivity to these
DNA damaging agents in human malignant glioma cells
expressing S-IkB, Y-IkB and SY-IkB proteins.
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MATERIALS AND METHODS
Cell lines and culture conditions
The established human malignant glioma cell line, MO54, was
used. The cells were kindly supplied from Dr RS Day, Cross
Cancer Institute, Edmonton, AB, Canada. Cells were cultured in
Dulbecco’s modified Eagle medium plus 10% fetal bovine serum
(Hyclone Laboratories, Inc., Logan, UT, USA) at 37°C with 95%
air and 5% carbon dioxide.
Mutant constructions and transfections
For S-IkB plasmid, the IkB-a cDNA (a kind gift from Dr J Inoue,
The Institute of Medical Science, University of Tokyo, Japan)
inserted into the pBluescript II S/K plasmid was used as a template
for further polymerase chain reaction (PCR) amplification.
Mutagenic primers for 32Ser to 32Arg and 36Ser to 36Arg, such as
MAD-LPU; 5¢-CGACCGCCACGACGCCGGCCTGGACGC-
CATGAAAGACG-3¢ and MAD-LPL; 5¢-CGCTTTCATG-
GCGTCCAGGCCGGCGTCGTGGCGGTCG-3¢, were used in
PCR reaction. The reaction mixture was as follows; 1 ml of
pB-MAD3 plasmid (37 mg ml–1), 1 ml of each primer (1 pmol
ml–1), 4 ml of 25 mM magnesium chloride, 5 ml of dNTP mix (2 mM
each), 0.5 ml of KOD polymerase (5 units ml–1), 5 ml of 10 ´ KOD
buffer and 34 ml of distilled water. PCR condition was 15 cycles of
30 s at 98°C, 30 s at 55°C and 2 min at 74°C with a final extension
at 72°C for 3 min. The mixture was treated with DpnI for the
degradation of the template plasmid. The plasmid sample was
introduced into Escherichia coli JM109 strain by electroporation.
After 1 h incubation with SOC medium, the cells were plated on
LB dishes containing ampicillin. The S-IkB-a cDNA inserted in
the pBluescript II S/K plasmid were refined by using QIAprep
Spin Miniprep kit (Qiagen, Germany) and checked by digestion
with EcoRI. Then, sequencing of the S-IkB-a cDNA was done
with a Prism Dye Primer Cycle Sequencing Kit (–21M13)
(Applied Biosystems, Foster City, CA, USA). The pBluescript II
S/K plasmid containing S-IkB-a cDNA and the expression vector,
pcDNA3 (Invitrogen, Leek, The Netherlands) were digested by
HindIII and XbaI. Then, the S-IkB-a cDNA was ligated into the
HindIII and XbaI sites of pcDNA3 using DNA ligation kit ver. 2
(Takara, Ohtsu, Shiga, Japan). This plasmid was named as
pcDNA3-S-IkB. For the Y-IkB plasmid, we used the mutagenic
primers for 42Tyr to 42Phe, such as MAD-YPU; 5¢-GAAAGAC-
GAGGAGTTCGAGCAGATGGTCAAGG-3¢ and MAD-YPL;
5¢-CCTTGACCATCTGCTCGAACTCCTCGTCTTTC-3¢ in the
PCR reaction. For the SY-IkB plasmid, the S-IkB-a cDNA was
used as a template and the mutagenic primers for 42Tyr to 42Phe
were used in PCR reaction. The expression plasmids of Y-IkB-a
cDNA (pcDNA3-Y-IkB) and SY-IkB-a cDNA (pcDNA3-
SY-IkB) were made by similar methods as above-mentioned. A
plasmid pcDNA3, without IkB-a cDNA, was used as a negative
control.
The methods of transfection were reported previously
(Miyakoshi et al, 1997; Yamagishi et al, 1997a). Approximately
106 cells of MO54 were transfected with 10 mg of pcDNA3-S-IkB,
pcDNA3-Y-IkB, pcDNA3-SY-IkB or pcDNA3 by the electropora-
tion with the unit (model X-CELL 2000, pds Inc., Madison, WI,
USA) operated at 800 V. The cells were then cultured in normal
medium for 36–48 h, and then cultured in the medium containing
G418 (400–800 mg ml–1). The cultures were maintained for 2–3
weeks until colonies were formed. The transfection frequencies of
these plasmids were 2–8 ´ 10–4.
Chemicals
Human TNF-a (Pepro Tech EC Ltd., London, UK) was dissolved
in distilled water and adriamycin (Wako Pure Chemical Industries,
Ltd, Osaka, Japan) was dissolved in medium at a concentration of
20 mg ml–1 and 500 mg ml–1 respectively. Herbimycin A (Sigma,
St Louis, MO, USA) and genistein (Fujikko Ltd, Kobe, Japan)
were dissolved in dimethylsulphoxide (DMSO) at a concentration
of 2 mg ml–1 and 20 mg ml–1 respectively. These solutions were
diluted in the medium at a final concentration and used for the
experiments.
Western immunoblots and immunoprecipitation
Details of Western immunoblottings were described elsewhere
(Miyakoshi et al, 1997). The antibodies used in this experiment
were as follows; anti-IkB-a/MAD3 antibody (C-21, Santa Cruz
Biotechnology, Inc., Santa Cruz, CA, USA), anti-b-actin antibody
(Sigma) and anti-NFkB/p65 antibody (C-20, Santa Cruz
Biotechnology). The immunoprecipitation was done by using
Protein A Sepharose (Pharmacia Biotechnology). The nuclear
extracts were prepared according to Schreiber et al (1989).
Autoradiography with enhanced chemiluminescence was done
according to the instructions by the manufacturer (Amersham
International plc, Buckinghamshire, UK). The densitometric
analysis was done by using NIH image 1.60.
X- and UV-irradiations and cell survival
Methods of X- and UV-irradiations and the analysis of cell
survival were described previously (Miyakoshi et al, 1996;
Yamagishi et al, 1997b). X-irradiation was performed using a
Hitachi MBR-1520 at 150 kVp, 20 mA with 0.5 mm Al and
0.1 mm Cu filters with a dose-rate of 0.98–1.02 Gy min–1. For UV
exposure, a bank of two 15 W Toshiba germicidal UV lamps
(predominantly 254 nm) was used with a dose rate of 1.2 J m–2 s–1.
Control plating efficiencies for the parental MO54 cells and the
transfected clones are ranged from 0.4 to 0.6. Five replicate plates
per experiment were used for each survival point and the experi-
ments were repeated at least three times. Cell survival was statisti-
cally analysed by the two-way analysis of variance and by t-test
for unpaired data.
Detection of apoptosis
Apoptosis Ladder Detection kit (Wako) was used. The cells were
treated with TNF-a (20 ng ml–1) for up to 12 h. DNA was
extracted and electrophoresed in agarose gel at 100 V. The gel was
stained with SYBR Green I (Molecular Probes, Eugene, OR,
USA).
Flow cytometry
Analysis of cell cycle distribution was described previously
(Miyakoshi et al, 1997). In brief, cells were suspended in phos-
phate-buffered saline (PBS) containing 0.1% Triton X-100 after
washing twice with PBS. RNAase (1 mg ml–1) (Sigma) was added
to the cell suspension and the cells were incubated for 30 min at30 J Miyakoshi and K Yagi
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37°C. Propidium iodide (Molecular Probes) was added at a final
concentration of 50 mg ml–1 and the cell suspension was left at 4°C
for 1 h. The cells were filtered through 50 mm nylon mesh before
flow cytometry with a FACScan system (Becton Dickinson Co.
Ltd, Franklin Lakes, NJ, USA).
RESULTS
X-ray sensitivity of cells expressing S-IkB, Y-IkB and
SY-IkB proteins
The expressions of IkB-a in the parental MO54 cells and their
S-IkB-, Y-IkB- and SY-IkB-introduced clones are shown in
Figure 1A. The clones, MO54-S8, MO54-Y2 and MO54-SY4,
were overexpressing S-IkB, Y-IkB and SY-IkB proteins respec-
tively, in which those proteins were non-phosphorylated type. The
radiation-dose survival curves of these clones, other expression
clones MO54-Y18 and MO54-SY6, the parental MO54 and the
negative control of MO54-V are shown in Figure 1B. MO54-S8,
MO54-Y2 and MO54-Y18 cells became radiosensitive as
compared with the parental MO54 and the vector-transfected
MO54-V cells. The cell clones expressing SY-IkB, MO54-SY4
and MO54-SY6, were further radiosensitive. The radiosensitiza-
tion was estimated from the ratio of mean surviving fraction for
the parental cells to that for cells expressing S-IkB, Y-IkB and SY-
IkB (Table 1). The calculated additive radiosensitizing value was
similar to the ratio of mean surviving fraction of cells expressing
SY-IkB. The extent of the radiosensitization in cells expressing
SY-IkB was almost additive at higher doses of 4 Gy and over,
which means addition of the radiosensitization in each clone
expressing S-IkB and Y-IkB. Changes in the amount of p65/RelA
protein in nuclear fraction was examined in cells after X-irradia-
tion. The relative amount of p65 protein in nuclear fraction from
MO54, MO54-S8, MO54-Y2 and MO54-SY4 cells after X-irradi-
ation is shown in Figure 2A. The constitutive level of p65 in
MO54-S8 and MO54-Y2 cells was lower than that in MO54 cells,
but this level in MO54-SY4 cells was still lower. After X-irradia-
tion, the amount of p65 in nucleus in MO54 cells was increasing,
while that in these clones did not change significantly. The amount
of IkB-a/NF-kB complex was also examined after X-irradiation.
The relative amount of IkB-a immunoprecipitated with anti-NF-
kB/p65 after X-irradiation is shown in Figure 2B. The constitutive
level of IkB-a/NF-kB complex observed in MO54-S8, MO54-Y2
and MO54-SY4 cells was higher than that in MO54 cells. After
X-irradiation, the amount of the complex in MO54-SY4 cells did
not change, but the amount in MO54, MO54-S8 and MO54-Y2
cells was decreased. The IkB-a/NF-kB complex was dissociated
and the amount was very low in MO54 cells after X-irradiation.
Effect of herbimycin A on X-ray sensitivity
We examined whether a phosphorylation inhibitor, herbimycin A,
can modify cellular X-ray sensitivity. MO54-S8, MO54-Y2,
MO54-Y18, MO54-SY4 and the parental cells were treated with
herbimycin A (1 mg ml–1) for 2 h, and then irradiated with X-rays.
Herbimycin A was removed at 1 h after X-irradiation. Figure 3
shows the X-ray dose–survival curves of these cells. The X-ray-
survival of MO54 cells was decreasing by herbimycin A, but did
not reach to the radiosensitivity level of those cells expressing
SY-IkB protein. The X-ray sensitivity of MO54-S8, MO54-Y2
and MO54-Y18 cells became almost similar level to that of
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sensitivity of the parental cells and the transfected clones. (A) The IkB-a
protein was detected using anti-IkB-a monoclonal antibody. After removing
antibody, the same blot was re-probed with the anti-b-actin monoclonal
antibody. (B) Exponentially growing cells were exposed to X-rays with
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Figure 2 The relative p65/RelA protein in nuclear fraction and the relative
amount of p65/IkB-a complex in MO54-S8, MO54-Y2, MO54-SY4 and the
parental MO54 cells after X-irradiation. (A) Nuclear extract was prepared
from the cells at 1 or 2 h following X-irradiation with 8 Gy. The p65/RelA
protein was detected using anti-NFkB/p65 antibody. (B) After 1 or 2 h
incubation following X-irradiation with 8 Gy, cell lysates were
immunoprecipitated with anti-NFkB/p65 antibody and then Western blot with
anti-IkB-a monoclonal antibody was done. Each point represents the mean
of the duplicate experiments. The densitometric analysis was done by using
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MO54-SY4 cells. However, the radiosensitivity of MO54-SY4
cells did not change by the treatment with herbimycin A.
Treatment with the other inhibitor, genistein (100 mgm l –1),
showed a similar trend to herbimycin A (data not shown).
Effect of TNF-a on DNA degradation, cell cycle
distribution and X-ray sensitivity
We examined the effect of TNF-a, one of the phosphorylation
stimuli, on DNA degradation, cell cycle distribution and X-ray
sensitivity. MO54-S8, MO54-Y2, MO54-SY4 and the parental
cells were treated with TNF-a (20 ng ml–1) for up to 12 h. Figure
4A shows the photographs of DNA gels. TNF-a-induced DNA
degradation was observed in MO54-S8, MO54-Y2 and MO54-
SY4 cells. The parental MO54 cells did not occur such DNA
degradation for up to a 12 h treatment with TNF-a. Patterns of cell
cycle distribution after X-irradiation or TNF-a treatment are
shown in Figure 4B. Typical G1 arrest and a decrease in S phase
ratio were observed in MO54 but not in MO54-SY4 cells after
X-irradiation. DNA degradations by the treatment with TNF-a for
Table 1 The radiosensitizing value estimated from the ratio of mean surviving fraction at 4, 6 and 8 Gy
X-ray dose Ratio of mean surviving fraction [SF(parental cells)/SF(clones)]
Parental cells S-IkB clone Y-IkB clones SY-IkB clones Calculated
(MO54) (MO54-S8) (MO54-Y2) (MO54-SY4) additive
(MO54-Y18) (MO54-SY6) radiosensitizing
value*
4 Gy (1.00) 1.36 2.52 3.75 3.43
6 Gy (1.00) 2.15 4.70 10.66 10.11
8 Gy (1.00) 7.11 8.50 70.59 60.44
The radiosensitizing value was estimated from the ratio of mean surviving fraction for the parental cells (MO54) to that for clones
expressing S-IkB (MO54-S8), Y-IkB (MO54-Y2 and MO54-Y18) and SY-IkB (MO54-SY4 and MO54-SY6). *The additive
radiosensitizing value for SY-IkB was calculated as a multiplication of the surviving fraction ratio for S-IkB and that for Y-IkB.
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Figure 4 Ethidium bromide-stained gels, cell cycle distribution and the
X-ray sensitivity of cells treated with TNF-a. (A) MO54-S8, MO54-Y2, MO54-
SY4 and the parental MO54 cells were treated with TNF-a (20 ng ml–1) for up
to 12 h. DNA from those cells was extracted and electrophoresed.
(B) Exponentially growing MO54 and MO54-SY4 cells were exposed to X-rays
with 5 Gy followed by a 20 h incubation or treated with TNF-a (20 ng ml–1) for
12 h, and then cell cycle distribution was analysed by quantitative flow
cytometry. Each experiment was repeated twice. (C) Exponentially growing
cells were treated with TNF-a (20 ng ml–1) for 4 h and then exposed to X-rays
with various doses. TNF-a was removed at 4 h after X-irradiation. Each point
represents the mean of the triplicate experiments with standard deviation32 J Miyakoshi and K Yagi
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12 h were detected in MO54-SY4 but not in the parental MO54
cels.
MO54-SY4 and MO54 cells were treated with TNF-a for 4 h
and then irradiated with X-rays. TNF-a was removed at 4 h after
X-irradiation. Figure 4C shows the X-ray dose–survival curves of
those cells. The toxicity of TNF-a alone, in which the surviving
fraction was 0.61 for MO54-SY4, was normalized in the survival
curves. No decrease in survival was observed in MO54 cells after
treatment with TNF-a. The radiosensitivity of MO54-SY4 cells
did not change by the treatment with TNF-a. The X-ray-survival
of MO54 cells at doses of 6 and 8 Gy was increasing slightly by
the treatment with TNF-a (P < 0.05).
Adriamycin and UV sensitivities
We examined the cellular sensitivity to other DNA damaging
agents, adriamycin and UV. Cell survival after adriamycin treat-
ment or UV-irradiation in MO54-S8, MO54-Y2, MO54-Y18,
MO54-SY4, MO54-V, and the parental cells are shown in Figure
5A and 5B. MO54-S8, MO54-Y2 and MO54-Y18 cells were
sensitive to adriamycin and UV. MO54-SY4 cells were further
sensitive to the both, the extent of the sensitization to adriamycin
and UV in cells expressing SY-IkB also being additive. Change in
the sensitivity to adriamycin and UV in those clones showed a
very similar trend to that in the X-ray sensitivity.
DISCUSSION
For the activation of NF-kB, two different pathways for the phos-
phorylation of IkB-a are demonstrated, one for serine (at residues
32 and 36) phosphorylation and the other for tyrosine (at residue
42) phosphorylation. Wang et al (1996) reported that inhibition of
NF-kB nuclear translocation by the introduction of S-IkB plasmid
into human fibrosarcoma cell line HT 1080 enhanced cell killing
by ionizing radiation. Our finding using MO54-S8 cells in this
study is consistent with their data (Figure 1B). In addition, the
clones expressing Y-IkB protein became radiosensitive and the
clones expressing SY-IkB protein were further radiosensitive
(Figure 1B). The extent of radiosensitization in cells expressing
SY-IkB is almost additive (Table 1). Changes in the nuclear
fraction of p65/Rel protein and the amount of NF-kB/IkB-a
complex after X-irradiation also depended on the status of IkB-a
phosphorylation (Figure 2). Therefore, the inhibition of phos-
phorylation at serine and tyrosine of IkB-a acts independently
on the radiosensitization of the cells.
Phosphorylation pathways are important for NF-kB activation.
Treatment with a phosphorylation inhibitor, herbimycin A or
genistein, inhibits radiation-induced NF-kB activation (Iwasaki et
al, 1992; Uckun et al, 1993). The X-ray sensitivity of MO54-SY4
cells did not change by the treatment with herbimycin A, while
that of the parental MO54 cells was enhanced by herbimycin A
(Figure 3). Genistein had a similar effect of herbimycin A on the
X-ray sensitivity of those cells (data not shown). Inhibition of
phosphorylations by herbimycin A sensitized cells to X-rays,
supports that the radiosensitization of cells expressing S-IkB, Y-
IkB and SY-IkB proteins could be, in part, due to the inhibition of
IkB-a phosphorylation.
The phosphorylation of IkB-a is induced by a variety of
activators, such as TNF-a, 12-O-tetradecanoylphorbol-13-acetate
(TPA) and interleukin (IL)-1, resulting in the induction of NF-kB
activation (Beg et al, 1993; Brown et al, 1993; Cordle et al, 1993;
Mellits et al, 1993). The expression of S-IkB protein potentiately
enhanced the ability of TNF-a to initiate apoptosis in a variety of
cells that are normally resistant to this cytokine, suggests that the
activation of NF-kB by TNF-a is protective (Wang et al, 1996).
Treatment with TNF-a induced DNA degradation in MO54-S8,
MO54-Y2 and MO54-SY4 cells, but not in the parental MO54
cells (Figure 4A). The results of cell cycle distribution of MO54-
SY4 and MO54 cells supported these observations (Figure 4B). By
the treatment with TNF-a, X-ray survivals of MO54-SY4 cells did
not change significantly, but those of MO54 cells increased
slightly (Figure 4C). Thus, the absence of NF-kB/p65 sensitized
cells to TNF-a, but an increase in cell killing induced by X-irradi-
ation in MO54-SY4 might be independent of the toxic action of
TNF-a, such as an induction of DNA degradation. In addition,
TNF-a-induced activation of NF-kB in MO54 cells may provide
protection against cell killing by X-rays.
For the response of cells to other DNA damaging agents, such
as adriamycin and UV, MO54-S8, MO54-Y2, MO54-Y18 and
MO54-SY4 cells became sensitive as compared with the parental
MO54 cells (Figure 5). In addition, changes in the sensitivity to
adriamycin and UV in those clones showed a very similar trend to
that in the X-ray sensitivity and the extent of these sensitizations in
cells expressing SY-IkB was also additive (Figure 5). Therefore,
the sensitization of those cells to adriamycin and UV was also
independently induced by the inhibition of serine and tyrosine
phosphorylations in IkB-a.
In the treatment of cancer, sensitivity or resistance of tumour
cells to ionizing radiation and anti-tumour chemical agents has
been substantial clinical consequences. However, molecular mech-
anisms and/or intrinsic factors controlling these cellular sensitivi-
ties are not fully understood in mammalian cells. In the present
study, an inactivation of NF-kB by inhibition of both phosphoryla-
tions at serine and tyrosine of IkB-a enhances the sensitivity to
X-rays and adriamycin in glioma cell line. The present findings
suggest that the transcriptional activation induced by NF-kB may
play a role in the repair of DNA damages. The present study also
proposes a possibility that the inactivation of NF-kB by inhibition
of both serine and tyrosine phosphorylations may be useful for the
treatment of cancer in radio- and chemotherapies.
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